ESLA
Price
$0.85
Change
+$0.04 (+4.94%)
Updated
Apr 3, 02:34 PM (EDT)
Capitalization
27.49M
NRXS
Price
$1.90
Change
-$0.25 (-11.63%)
Updated
Apr 3, 01:53 PM (EDT)
Capitalization
15.23M
48 days until earnings call
Ad is loading...

ESLA vs NRXS

Header iconESLA vs NRXS Comparison
Open Charts ESLA vs NRXSBanner chart's image
Estrella Immunopharma
Price$0.85
Change+$0.04 (+4.94%)
Volume$1.5K
Capitalization27.49M
Neuraxis
Price$1.90
Change-$0.25 (-11.63%)
Volume$100
Capitalization15.23M
ESLA vs NRXS Comparison Chart
Loading...
ESLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ESLA vs. NRXS commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ESLA is a Hold and NRXS is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (ESLA: $0.81 vs. NRXS: $2.15)
Brand notoriety: ESLA and NRXS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ESLA: 52% vs. NRXS: 245%
Market capitalization -- ESLA: $27.49M vs. NRXS: $15.23M
ESLA [@Biotechnology] is valued at $27.49M. NRXS’s [@Biotechnology] market capitalization is $15.23M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ESLA’s FA Score shows that 0 FA rating(s) are green whileNRXS’s FA Score has 0 green FA rating(s).

  • ESLA’s FA Score: 0 green, 5 red.
  • NRXS’s FA Score: 0 green, 5 red.
According to our system of comparison, NRXS is a better buy in the long-term than ESLA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ESLA’s TA Score shows that 4 TA indicator(s) are bullish while NRXS’s TA Score has 3 bullish TA indicator(s).

  • ESLA’s TA Score: 4 bullish, 6 bearish.
  • NRXS’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, both ESLA and NRXS are a bad buy in the short-term.

Price Growth

ESLA (@Biotechnology) experienced а -17.24% price change this week, while NRXS (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.30%. For the same industry, the average monthly price growth was -10.41%, and the average quarterly price growth was -14.40%.

Reported Earning Dates

ESLA is expected to report earnings on Mar 14, 2023.

NRXS is expected to report earnings on May 21, 2025.

Industries' Descriptions

@Biotechnology (-8.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ESLA($27.5M) has a higher market cap than NRXS($15.2M). NRXS YTD gains are higher at: -8.511 vs. ESLA (-32.417). NRXS has higher annual earnings (EBITDA): -8.02M vs. ESLA (-8.82M). ESLA has more cash in the bank: 1.8M vs. NRXS (261K). NRXS has higher revenues than ESLA: NRXS (2.46M) vs ESLA (0).
ESLANRXSESLA / NRXS
Capitalization27.5M15.2M181%
EBITDA-8.82M-8.02M110%
Gain YTD-32.417-8.511381%
P/E RatioN/AN/A-
Revenue02.46M-
Total Cash1.8M261K689%
Total DebtN/A477K-
TECHNICAL ANALYSIS
Technical Analysis
ESLANRXS
RSI
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
57%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
54%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
43%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
63%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
71%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 23 days ago
75%
N/A
Declines
ODDS (%)
Bearish Trend 7 days ago
85%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
ESLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OCGN0.690.04
+6.46%
Ocugen
ASAN16.040.73
+4.77%
Asana
PRLB36.290.90
+2.54%
Proto Labs
CTRA28.99-0.08
-0.28%
Coterra Energy
SYBX1.20-0.02
-1.64%
Synlogic

ESLA and

Correlation & Price change

A.I.dvisor tells us that ESLA and IONS have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ESLA and IONS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ESLA
1D Price
Change %
ESLA100%
+6.71%
IONS - ESLA
28%
Poorly correlated
+5.32%
IMUX - ESLA
25%
Poorly correlated
+4.23%
CARM - ESLA
25%
Poorly correlated
-3.60%
WINT - ESLA
25%
Poorly correlated
+15.83%
CYTOF - ESLA
23%
Poorly correlated
-2.85%
More

NRXS and

Correlation & Price change

A.I.dvisor tells us that NRXS and NGNE have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NRXS and NGNE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRXS
1D Price
Change %
NRXS100%
+1.90%
NGNE - NRXS
24%
Poorly correlated
+8.34%
TCRT - NRXS
23%
Poorly correlated
+29.63%
ESLA - NRXS
22%
Poorly correlated
+6.71%
VTYX - NRXS
21%
Poorly correlated
-0.93%
TBPH - NRXS
21%
Poorly correlated
-0.11%
More